Metabolic
Liraglutide
Also called Victoza, Saxenda, NN2211
InjectableEvidence AEvery day
per administration
Tested in people
A human trial worked out how much to take and how often, so a dosing schedule is shown.
Licensed as a medicine in the US and EU.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 2mg/mL
- Volume per draw
- 0.3mL
- Units to dial
- 30
- Doses per cartridge
- 10
Vial label
Copy this into your label printer.
Published research contexts for Liraglutide describe 0.6–3 mg per administration. Descriptive only, not a recommendation.
Dosing schedule
How Liraglutide is commonly stepped up, for reference only.
These are commonly-discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified professional.
| Phase | Amount | Frequency | Route |
|---|---|---|---|
| Week 1Starting step to limit gastrointestinal effects; stepped up weekly. | 0.6 mg | Once daily | SubQ |
| Week 2 | 1.2 mg | Once daily | SubQ |
| Week 3 | 1.8 mg | Once daily | SubQ |
| Week 4 | 2.4 mg | Once daily | SubQ |
| Week 5+Highest step reported in SCALE; reached only as tolerated. | 3.0 mg | Once daily | SubQ |
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.39× single dose
- Time to steady state
- 2.7days
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- SCALE Obesity and Prediabetes (Pi-Sunyer X et al., NEJM 2015;373:11)A GLP-1 receptor agonist; once-daily liraglutide escalated by weekly 0.6 mg steps to 3.0 mg for weight management in adults with obesity.